63 related articles for article (PubMed ID: 17728167)
21. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity?
Laron Z
Mech Ageing Dev; 2005 Feb; 126(2):305-7. PubMed ID: 15621211
[TBL] [Abstract][Full Text] [Related]
22. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).
Laron Z
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():231-49. PubMed ID: 10698588
[TBL] [Abstract][Full Text] [Related]
23. Genetic disorders in the growth hormone - insulin-like growth factor-I axis.
Walenkamp MJ; Wit JM
Horm Res; 2006; 66(5):221-30. PubMed ID: 16917171
[TBL] [Abstract][Full Text] [Related]
24. Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report.
Moia S; Tessaris D; Einaudi S; de Sanctis L; Bona G; Bellone S; Prodam F
Ital J Pediatr; 2017 Oct; 43(1):94. PubMed ID: 29025428
[TBL] [Abstract][Full Text] [Related]
25. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C
Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322
[TBL] [Abstract][Full Text] [Related]
26. For debate: did the small-bodied hominis from flores (Indonesia) suffer from a molecular defect in the growth hormone receptor gene (Laron syndrome)?
Laron Z; Kornreich L; Hershkovitz I
Pediatr Endocrinol Rev; 2006 Jun; 3(4):345-6. PubMed ID: 16816802
[No Abstract] [Full Text] [Related]
27. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.
Laron Z; Kauli R; Lapkina L; Werner H
Mutat Res Rev Mutat Res; 2017; 772():123-133. PubMed ID: 28528685
[TBL] [Abstract][Full Text] [Related]
28. Laron syndrome - A historical perspective.
Laron Z; Werner H
Rev Endocr Metab Disord; 2021 Mar; 22(1):31-41. PubMed ID: 32964395
[TBL] [Abstract][Full Text] [Related]
29. [Laron syndrome by loss of functions of growth hormone receptor].
Kaji H
Nihon Rinsho; 2002 Feb; 60(2):306-12. PubMed ID: 11857918
[TBL] [Abstract][Full Text] [Related]
30. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.
Laron Z
J Clin Endocrinol Metab; 1995 May; 80(5):1526-31. PubMed ID: 7744997
[TBL] [Abstract][Full Text] [Related]
31. Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model.
Laron Z
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():188-91. PubMed ID: 16641857
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and therapeutic advances in growth hormone insensitivity.
David A; Metherell LA; Clark AJ; Camacho-Hübner C; Savage MO
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):581-95, viii. PubMed ID: 16085161
[TBL] [Abstract][Full Text] [Related]
33. [Short stature investigation: clinical, laboratorial and genetic aspects concerning the growth hormone insensitivity (GHI)].
Jorge AA
Arq Bras Endocrinol Metabol; 2008 Aug; 52(6):1056-65. PubMed ID: 18820818
[TBL] [Abstract][Full Text] [Related]
34. Genetic defects of the growth-hormone-IGF axis associated with growth hormone insensitivity.
Woods K
Endocr Dev; 2007; 11():6-15. PubMed ID: 17986822
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
36. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
Guevara-Aguirre J; Bautista C; Torres C; Peña G; Guevara C; Palacios C; Guevara A; Gavilanes AWD
Rev Endocr Metab Disord; 2021 Mar; 22(1):59-70. PubMed ID: 33047268
[TBL] [Abstract][Full Text] [Related]
37. MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?
Basu R; Qian Y; Kopchick JJ
Eur J Endocrinol; 2018 May; 178(5):R155-R181. PubMed ID: 29459441
[TBL] [Abstract][Full Text] [Related]
38. [Molecular genetic of growth hormone resistance syndrome].
Amselem S; Sobrier ML; Duquesnoy P; Goossens M
Ann Endocrinol (Paris); 1991; 52(6):474-8. PubMed ID: 1824502
[TBL] [Abstract][Full Text] [Related]
39. Point mutations in the growth hormone receptor gene of patients with Laron syndrome.
Amselem S; Duriez B; Sobrier ML; Duquesnoy P; Goossens M
Acta Paediatr Suppl; 1992 Sep; 383():132-3. PubMed ID: 1458008
[No Abstract] [Full Text] [Related]
40. Clinical significance and molecular mechanisms of bioinactive growth hormone (review).
Takahashi Y; Chihara K
Int J Mol Med; 1998 Sep; 2(3):287-91. PubMed ID: 9855700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
